Incept uses investments in traditional area such as resources and industry and access to non-traditional finance to fund disruptive innovations. Incept has a growing portfolio of early-stage disruptive companies in areas ranging from clean energy, medicine, new materials and carbon credits. Non-traditional finance can include bond financing, underwriting, cryptocurrencies and block chain.

Disruptive innovation is a term in the field of business administration which refers to an innovation that creates a new market and value network and eventually disrupts an existing market and value network, displacing established market leading firms, products, and alliances.

Incept believes in pursuing large ambitions and focusing on long-term growth over short-term profitability. Incept believes that founders are best positioned to lead their start-ups, and that they should retain substantial equity and control and is focussed on building businesses that can dominate across multiple geographies.

A financing diagram illustrating how start-up companies are typically financed. First, the new firm seeks out “seed capital” and funding from “angel investors” and accelerators. Then, if the firm can survive through the “valley of death”–the period where the firm is trying to develop on a “shoestring” budget–the firm can seek venture capital financing. Incept provides the funding for start-up companies until their IPO.


The company has combined the application of scientific knowledge for practical purposes in the existing field of Industrial Technology to engineer and apply some of the world’s latest science. The company’s technology-focused model reinforces the company’s position as a participant in the global clean energy, resource and commodity sectors. This ascertains Incept as a future global innovative market leader, with several uniquely patented Industrial technologies.



The company aims to be a fully vertically integrated agri-foods business covering livestock and crops. It will introduce technologies in supplements, robotics for plantlet production, waste water, livestock and cropping management and supplements to turnaround struggling businesses. This includes developing new technologies for desertification as climate change occurs – alternative crops, nutrition and drip irrigation. In the countries where the agricultural business operates Incept will actively seek aligned opportunities in property and infrastructure.



The company considers renewable energy and water are essential to the world’s future economic growth and prosperity in a carbon-constrained world and to helping lower global carbon emissions through its portfolio of intellectual property. This includes making the most of the sun (solar) and technology , perpetual energy to conversion of seawater and other perpetual energy systems. The company is working on new battery systems as future replacement for lithium. The company has positioned its assets to satisfy the strong resource demand from the world’s major urbanisation growth markets with the aim of reducing carbon emissions and developing carbon credits in developing countries (including afforestation and forestry management) to offset carbon production in urbanised countries.



The company seeks to deliver exceptional stakeholder value through resource assets of deposits of iron ore, gold, copper, coal, lithium and other precious metals in an efficient, environmentally accountable and profitable manner.



The promise of technology breakthroughs allows the development of new industries. The company is continuously assessing technologies in the areas of genomics, artificial intelligence, robotics, mobility & transport, materials science and deep space.



The company is testing revolutionary thinking in the medical industry such as treating the problem of human disease at the stem or root cause for such disease within the human body. Human disease stems from the improper orientation for cell polarity involved in the disease. As an example, through the generation of this deeply penetrating, controlled gamma rays are directed in a safe manner into the human body so as to specifically target, reprogram and regenerate new cells via the repolarisation of the damaged or diseased cells. Alternatively, traditional therapies have been known to cure terminal diseases at low cost and nearly 100% efficacy. The company is investing carefully in novel Information Technology projects in the are of security and e-commerce.



The application of new technology to provide innovation and lower cost to infrastructure development. This is further supported by innovative funding for infrastructure and technology development.